Approach to Hyponatremia
Initial Assessment and Classification
Begin by confirming true hypotonic hyponatremia through serum osmolality (<275 mOsm/kg) and exclude pseudohyponatremia from hyperglycemia by correcting sodium (add 1.6 mEq/L for each 100 mg/dL glucose >100 mg/dL). 1
The diagnostic workup should include:
- Serum and urine osmolality to confirm hypotonic hyponatremia and assess water excretion capacity 2
- Urine sodium concentration to differentiate between causes (>20-40 mmol/L suggests SIADH or renal losses; <30 mmol/L suggests extrarenal losses) 2, 3
- Serum creatinine, thyroid function (TSH), and cortisol to exclude endocrine causes 1
- Assessment of extracellular fluid volume status through physical examination, looking for orthostatic hypotension, dry mucous membranes (hypovolemia), or peripheral edema, ascites, jugular venous distention (hypervolemia) 2, 1
Treatment Based on Symptom Severity
Severe Symptomatic Hyponatremia (Medical Emergency)
For patients with severe symptoms (seizures, coma, altered mental status, cardiorespiratory distress), immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours or until symptoms resolve. 2, 1
- Give 100 mL boluses of 3% saline over 10 minutes, repeatable up to three times at 10-minute intervals until symptoms improve 1, 4
- Never exceed 8 mmol/L total correction in 24 hours to prevent osmotic demyelination syndrome 2, 1, 3
- Monitor serum sodium every 2 hours during initial correction 2, 1
Asymptomatic or Mildly Symptomatic Hyponatremia
Treatment is based on volume status and underlying etiology, with slower correction rates 2, 1
Treatment Based on Volume Status
Hypovolemic Hyponatremia
Discontinue diuretics immediately and administer isotonic (0.9%) saline for volume repletion. 2, 1
- Initial infusion rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on response 2
- Urine sodium <30 mmol/L predicts good response to saline (positive predictive value 71-100%) 2
- Once euvolemic, reassess and adjust treatment based on sodium response 2
Euvolemic Hyponatremia (SIADH)
Fluid restriction to 1 L/day is the cornerstone of treatment for SIADH. 2, 1, 3
- If no response to fluid restriction, add oral sodium chloride 100 mEq three times daily 2
- For persistent cases, consider vasopressin receptor antagonists (tolvaptan 15 mg once daily) with careful monitoring 2, 5
- Alternative options include urea, demeclocycline, or lithium for resistant cases 2
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L and treat the underlying condition. 2, 1
- Temporarily discontinue diuretics if sodium <125 mmol/L 2, 1
- For cirrhotic patients, consider albumin infusion alongside fluid restriction 2, 1
- Avoid hypertonic saline unless life-threatening symptoms are present, as it worsens ascites and edema 2
- Tolvaptan may be considered for persistent severe hyponatremia despite fluid restriction, but use with extreme caution in cirrhosis due to 10% risk of gastrointestinal bleeding (vs. 2% placebo) 2, 5
Correction Rate Guidelines by Severity
The single most critical principle: never exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome. 2, 1, 3
Standard Correction Rates
- Serum sodium 126-135 mmol/L: Continue current therapy with close electrolyte monitoring; no water restriction needed 1
- Serum sodium 121-125 mmol/L: More cautious approach; consider stopping diuretics 1
- Serum sodium <120 mmol/L: Stop diuretics immediately; implement severe fluid restriction plus albumin infusion or volume expansion 1
High-Risk Populations Requiring Slower Correction (4-6 mmol/L per day maximum)
Patients with advanced liver disease, alcoholism, malnutrition, or prior encephalopathy require even more cautious correction due to dramatically higher risk of osmotic demyelination syndrome. 2, 1, 3
Additional high-risk factors include:
Special Considerations for Neurosurgical Patients
In neurosurgical patients, distinguishing between SIADH and cerebral salt wasting (CSW) is critical, as treatments are opposite. 2
SIADH Characteristics
- Euvolemic state with normal to slightly elevated central venous pressure 2
- Urine sodium >20-40 mmol/L with urine osmolality >300 mOsm/kg 2
- Treatment: Fluid restriction to 1 L/day 2
Cerebral Salt Wasting Characteristics
- True hypovolemia with CVP <6 cm H₂O 2
- Urine sodium >20 mmol/L despite volume depletion 2
- Clinical signs: orthostatic hypotension, dry mucous membranes 2
- Treatment: Volume and sodium replacement with isotonic or hypertonic saline, NEVER fluid restriction 2
- For severe symptoms, add fludrocortisone 0.1-0.2 mg daily 2
- Never use fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 2
Management of Overcorrection
If sodium correction exceeds 8 mmol/L in 24 hours, this is a medical emergency requiring immediate intervention. 2, 1
- Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 2, 1
- Consider administering desmopressin to slow or reverse the rapid rise 2, 1
- Target reduction to bring total 24-hour correction to no more than 8 mmol/L from starting point 2
Monitoring During Treatment
Severe Symptoms
- Check serum sodium every 2 hours during initial correction 2, 1
- After symptom resolution, check every 4 hours 2
Mild Symptoms or Asymptomatic
- Check every 4 hours initially, then daily until target sodium achieved 1
- Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction 2
Common Pitfalls to Avoid
- Never ignore mild hyponatremia (130-135 mmol/L) as it increases fall risk (21% vs. 5%) and mortality (60-fold increase with sodium <130 mmol/L) 2, 3
- Never use fluid restriction in cerebral salt wasting as this worsens outcomes 2
- Never use hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms as it worsens fluid overload 2
- Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours to avoid osmotic demyelination syndrome 2, 1, 3
- Never delay treatment while pursuing diagnosis in severely symptomatic patients 4
- Inadequate monitoring during active correction can lead to overcorrection 2